Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000

Alberto E Tozzi; Alfredo Caprioli; Fabio Minelli; Alessandra Gianviti; Laura De Petris; Alberto Edefonti; Giovanni Montini; Alfonso Ferretti; Tommaso De Palo; Maurizio Gaido; Gianfranco Rizzoni; Hemolytic Uremic Syndrome Study Group

doi:10.3201/eid0901.020266

Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000

Emerg Infect Dis. 2003 Jan;9(1):106-8. doi: 10.3201/eid0901.020266.

Authors

Alberto E Tozzi¹, Alfredo Caprioli, Fabio Minelli, Alessandra Gianviti, Laura De Petris, Alberto Edefonti, Giovanni Montini, Alfonso Ferretti, Tommaso De Palo, Maurizio Gaido, Gianfranco Rizzoni; Hemolytic Uremic Syndrome Study Group

Affiliation

¹ Department of Communicable Disease, Unit of Epidemiology and Biostatistics, Istituto Superiore di Sanità, V. le R. Elena 299 00161 Roma, Italy. [email protected]

Abstract

The mean annual incidence of hemolytic uremic syndrome in persons </=15 years of age in Italy from 1988 to 2000 was 0.28 per 100,000 population. Laboratory investigations showed that Shiga toxin-producing Escherichia coli (STEC) infection occurred in 73.1% of patients. STEC O157 was the most common serotype, but a considerable number of cases were from infections by non-O157 STEC.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Child, Preschool
Escherichia coli / classification
Escherichia coli / isolation & purification*
Escherichia coli / metabolism
Escherichia coli Infections / epidemiology*
Escherichia coli Infections / microbiology
Escherichia coli O157 / classification
Escherichia coli O157 / isolation & purification
Escherichia coli O157 / metabolism
Hemolytic-Uremic Syndrome / epidemiology*
Hemolytic-Uremic Syndrome / microbiology
Humans
Incidence
Italy / epidemiology
Population Surveillance*
Serotyping
Shiga Toxin / biosynthesis*

Substances

Shiga Toxin